Similar articles for PMID: 15974599

Year	Number of Results
1980	1
1995	2
1996	1
1997	2
1998	2
1999	1
2000	1
2001	2
2002	1
2004	4
2005	10
2006	12
2007	23
2008	17
2009	15
2010	7
2011	4
2013	2
2014	1
2017	1
2024	0

1

A new synthetic agent with potent but selective cytotoxic activity against cancer.

Cholody WM, Kosakowska-Cholody T, Hollingshead MG, Hariprakasha HK, Michejda CJ. Cholody WM, et al. J Med Chem. 2005 Jun 30;48(13):4474-81. doi: 10.1021/jm048946x. J Med Chem. 2005. PMID: 15974599

2

Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.

Berry JM, Bradshaw TD, Fichtner I, Ren R, Schwalbe CH, Wells G, Chew EH, Stevens MF, Westwell AD. Berry JM, et al. J Med Chem. 2005 Jan 27;48(2):639-44. doi: 10.1021/jm040859h. J Med Chem. 2005. PMID: 15658878

3

Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.

Hernandez L, Cholody WM, Hudson EA, Resau JH, Pauly G, Michejda CJ. Hernandez L, et al. Cancer Res. 1995 Jun 1;55(11):2338-45. Cancer Res. 1995. PMID: 7757985

4

Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.

Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Stevens MF, Westwell AD. Mortimer CG, et al. J Med Chem. 2006 Jan 12;49(1):179-85. doi: 10.1021/jm050942k. J Med Chem. 2006. PMID: 16392802

5

Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.

Teng CH, Won SJ, Lin CN. Teng CH, et al. Bioorg Med Chem. 2005 May 16;13(10):3439-45. doi: 10.1016/j.bmc.2005.03.001. Bioorg Med Chem. 2005. PMID: 15848756

6

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

Milacic V, Chen D, Ronconi L, Landis-Piwowar KR, Fregona D, Dou QP. Milacic V, et al. Cancer Res. 2006 Nov 1;66(21):10478-86. doi: 10.1158/0008-5472.CAN-06-3017. Cancer Res. 2006. PMID: 17079469

7

R-253 disrupts microtubule networks in multiple tumor cell lines.

Gururaja TL, Goff D, Kinoshita T, Goldstein E, Yung S, McLaughlin J, Pali E, Huang J, Singh R, Daniel-Issakani S, Hitoshi Y, Cooper RD, Payan DG. Gururaja TL, et al. Clin Cancer Res. 2006 Jun 15;12(12):3831-42. doi: 10.1158/1078-0432.CCR-06-0168. Clin Cancer Res. 2006. PMID: 16778111

8

In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.

Momekov GTs, Ugrinova I, Pasheva EA, Bakalova AG, Varbanov HP, Ferdinandov DV, Ivanov DS, Konstantinov SM. Momekov GTs, et al. Ann N Y Acad Sci. 2009 Aug;1171:649-58. doi: 10.1111/j.1749-6632.2009.04693.x. Ann N Y Acad Sci. 2009. PMID: 19723116

9

Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.

Engel D, Nudelman A, Tarasenko N, Levovich I, Makarovsky I, Sochotnikov S, Tarasenko I, Rephaeli A. Engel D, et al. J Med Chem. 2008 Jan 24;51(2):314-23. doi: 10.1021/jm7009827. Epub 2007 Dec 29. J Med Chem. 2008. PMID: 18163551

10

Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.

Ohba T, Yamauch T, Higashiyama K, Takahashi N. Ohba T, et al. Bioorg Med Chem. 2007 Jan 15;15(2):847-53. doi: 10.1016/j.bmc.2006.10.042. Epub 2006 Oct 25. Bioorg Med Chem. 2007. PMID: 17092729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year